Engility® trial management platform developed by PHARMASEAL provides a solution to overcome many traditional challenges in clinical trial management. With centralised data on all clinical trials encompassing clinical trial management processes including study management, flexible monitoring, issue management, investigator payments, site and contract management and now including integrated eTMF document storage. This reduces data duplication, removes the need to integrate disparate systems and increases overall trial oversight and governance. Engility promotes distributed trial management and improved collaboration with sponsors, CRO’s and other service providers.
Clinical trial needs have evolved so does existing CTMS and eTMF technology that is currently available. Engility CTMS is the ideal technology if you’re a business currently using other methods to support your trials or looking for a replacement trial management system. Now with the added benefit of eTMF document storage, you don’t have to choose between two systems. CTMS is the “brain” and eTMF the “memory” enabling users to know what’s happening in the process at all times via a consolidated standalone solution.”
PHARMASEAL would like to offer a life science organisation free access to their Engility Platform in return for BETA testing – contact CEO Daljit Cheema daljit.cheema@pharmaseal.co
